T. Mikosch et al., SECRETION OF ACTIVE HUMAN MUCUS PROTEINASE-INHIBITOR BY ASPERGILLUS-NIGER AFTER KEX2-LIKE PROCESSING OF A GLUCOAMYLASE-INHIBITOR FUSION PROTEIN, Journal of biotechnology, 52(2), 1996, pp. 97-106
We report the production of human mucus proteinase inhibitor (MPI) by
the filamentous fungus Aspergillus niger to test the ability of this h
ost organism to secrete low molecular weight, highly disulfide-bonded
proteins in biologically active conformation. Fungal transformants hav
e been obtained with an expression cassette consisting of a chimeric g
ene founded on a mpi cDNA, encoding mature MPI, fused in frame to sequ
ences encoding A. niger glucoamylase (glaA), separated by a KEX2-like
processing sequence. Expression of the glucoamylase fusion gene in the
se transformants resulted in secretion of MPI into the growth medium w
ith yields up to 3 mg l(-1) N-terminal sequence analysis of the purifi
ed inhibitor confirmed that the glucoamylase-MPI fusion protein was co
rrectly processed to mature MPI by a KEX2-type endopeptidase present i
n A. niger. Furthermore, recombinant MPI retains full inhibitory activ
ity against chymotrypsin and leukocyte elastase indicating that the pr
otein was folded properly. (C) 1996 Elsevier Science B.V. All rights r
eserved.